Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2003000200 - ß-2'-OU 3'-HALONUCLEOSIDES

Numéro de publication WO/2003/000200
Date de publication 03.01.2003
N° de la demande internationale PCT/US2002/020245
Date du dépôt international 24.06.2002
Demande présentée en vertu du Chapitre 2 09.01.2003
CIB
C07H 9/04 2006.01
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
HSUCRES; LEURS DÉRIVÉS; NUCLÉOSIDES; NUCLÉOTIDES; ACIDES NUCLÉIQUES
9Composés contenant un hétérocycle partageant au moins deux hétéro-atomes avec un radical saccharide
02Hétérocycle contenant uniquement des atomes d'oxygène comme hétéro-atomes du cycle
04Acétals cycliques
C07H 19/06 2006.01
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
HSUCRES; LEURS DÉRIVÉS; NUCLÉOSIDES; NUCLÉOTIDES; ACIDES NUCLÉIQUES
19Composés contenant un hétérocycle partageant un hétéro-atome du cycle avec un radical saccharide; Nucléosides; Mononucléotides; Leurs anhydro-dérivés
02partageant un azote
04Radicaux hétérocycliques contenant uniquement des atomes d'azote comme hétéro-atomes du cycle
06Radicaux pyrimidine
CPC
A61K 31/52
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
52Purines, e.g. adenine
A61K 31/522
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two ; or more; nitrogen atoms as the only ring heteroatoms, e.g. piperazine ; or tetrazines
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
52Purines, e.g. adenine
522having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 31/675
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
66Phosphorus compounds
675having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K 31/70
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
C07H 19/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
19Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof
02sharing nitrogen
04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
06Pyrimidine radicals
C07H 9/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
9Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
02the hetero ring containing only oxygen as ring hetero atoms
04Cyclic acetals
Déposants
  • PHARMASSET LTD. [BB/BB]; c/o Corporate Services Limited The Financial Services Center Bishop's Ct. Hill P.O. Box 111 St Michael, BB (AllExceptUS)
  • UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. [US/US]; Boyd Graduate Research Foundation, Inc. Athens, GA 30602-7411, US (AllExceptUS)
  • EMORY UNIVERSITY [US/US]; 1380 S. Oxford Road Atlanta, GA 30322, US (AllExceptUS)
  • CHU, Chung, K. [US/US]; US (UsOnly)
  • OTTO, Michael, J. [US/US]; US (UsOnly)
  • SHI, Junxing [CN/US]; US (UsOnly)
  • SCHINAZI, Raymond, F. [US/US]; US (UsOnly)
  • CHOI, Yongseok [KR/US]; US (UsOnly)
  • GUMINA, Giuseppe [IT/US]; US (UsOnly)
  • CHONG, Youhoon [KR/US]; US (UsOnly)
  • STUYVER, Lieven, J. [BE/US]; US (UsOnly)
Inventeurs
  • CHU, Chung, K.; US
  • OTTO, Michael, J.; US
  • SHI, Junxing; US
  • SCHINAZI, Raymond, F.; US
  • CHOI, Yongseok; US
  • GUMINA, Giuseppe; US
  • CHONG, Youhoon; US
  • STUYVER, Lieven, J.; US
Mandataires
  • KNOWLES, Sherry, M. ; King & Spalding 191 Peachtree St. Atlanta, GA 30303-1763, US
Données relatives à la priorité
60/300,35622.06.2001US
60/305,38613.07.2001US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) $g(b)-2'-OR 3'-HALONUCLEOSIDES
(FR) ß-2'-OU 3'-HALONUCLEOSIDES
Abrégé
(EN)
The present invention includes compounds and compositions of $g(b)-halonucleosides, as well as methods to treat HIV, HBV or abnormal cellular proliferation comprising administering said compounds or compositions.
(FR)
L'invention concerne des composés et des compositions de ß-halonucléosides, ainsi que des procédés de traitement du VIH, du virus de l'hépatite B ou de la prolifération cellulaire anormale qui consistent à administrer lesdits composés ou lesdites compositions.
Dernières données bibliographiques dont dispose le Bureau international